To compare the future with every intractable disease treatment by power of chemistry,Chemiteras works on realization of "non-illness" of there day and night.
Chemiteras,Inc. | |
---|---|
Company name | Chemiteras,Inc. |
Head Office | 3-chome-24-5 Shinnyokohama,Kohoku Ward, Yokohama, Kanagawa, 222-0033, Japan |
company representative | Tokinori Terada |
foundation | 2017.9.13 |
Business | Investigation, Acquisition, Selling of in-house development medicina and product |
E-mail address | info@chemiteras.com |
E-mail address | info@chemiteras.com |
Nov.2020 |
Our SDG's project "UNIFY" in Switzerland was featured in the G20 report. UNIFY is a platform that supports researchers and their work around the world and connects people, companies, and research, and is attracting attention for accelerating the SDG's by utilizing UNIFY. ■G20 Report (UNIFY is on pages 156 and 157) This report is subscribed to by heads of state, government executives, Forbes 500 executives, and first class passengers. |
---|---|
Aug.2019 |
Signed an advisory agreement with Dr. Torkel Falkenberg, Representative at the Board of the Swedish Karolinska Institute (the world's best medical research institution). |
Mar.2019 | Joint development medicina: Patent applications of Cancer therapeutic drug of the brain |
Feb.2019 | In-house development medicina: Patent application of the mitochondrial related medicine |
Aug.2018 | In-house development medicina: Patent applications of Hyperuricemia therapeutic drug |
Mar.2019 | Joint development medicina: Patent applications of Cancer therapeutic drug of the brain |